BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 21061181)

  • 1. Role of p53 and β-catenin mutations in conjunction with CK19 expression on early tumor recurrence and prognosis of hepatocellular carcinoma.
    Yuan RH; Jeng YM; Hu RH; Lai PL; Lee PH; Cheng CC; Hsu HC
    J Gastrointest Surg; 2011 Feb; 15(2):321-9. PubMed ID: 21061181
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Increased Trimethylation of histone H3K36 associates with biliary differentiation and predicts poor prognosis in resectable hepatocellular carcinoma.
    Lien HC; Jeng YM; Jhuang YL; Yuan RH
    PLoS One; 2018; 13(10):e0206261. PubMed ID: 30356299
    [TBL] [Abstract][Full Text] [Related]  

  • 3. S100P expression is a novel prognostic factor in hepatocellular carcinoma and predicts survival in patients with high tumor stage or early recurrent tumors.
    Yuan RH; Chang KT; Chen YL; Hsu HC; Lee PH; Lai PL; Jeng YM
    PLoS One; 2013; 8(6):e65501. PubMed ID: 23785431
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression of bile duct transcription factor HNF1β predicts early tumor recurrence and is a stage-independent prognostic factor in hepatocellular carcinoma.
    Yuan RH; Lai HS; Hsu HC; Lai PL; Jeng YM
    J Gastrointest Surg; 2014 Oct; 18(10):1784-94. PubMed ID: 25052070
    [TBL] [Abstract][Full Text] [Related]  

  • 5. High alpha-fetoprotein level correlates with high stage, early recurrence and poor prognosis of hepatocellular carcinoma: significance of hepatitis virus infection, age, p53 and beta-catenin mutations.
    Peng SY; Chen WJ; Lai PL; Jeng YM; Sheu JC; Hsu HC
    Int J Cancer; 2004 Oct; 112(1):44-50. PubMed ID: 15305374
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CK19 and Glypican 3 Expression Profiling in the Prognostic Indication for Patients with HCC after Surgical Resection.
    Feng J; Zhu R; Chang C; Yu L; Cao F; Zhu G; Chen F; Xia H; Lv F; Zhang S; Sun L
    PLoS One; 2016; 11(3):e0151501. PubMed ID: 26977595
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The clinicopathological and prognostic relevance of cytokeratin 7 and 19 expression in hepatocellular carcinoma. A possible progenitor cell origin.
    Durnez A; Verslype C; Nevens F; Fevery J; Aerts R; Pirenne J; Lesaffre E; Libbrecht L; Desmet V; Roskams T
    Histopathology; 2006 Aug; 49(2):138-51. PubMed ID: 16879391
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Combined Chibby and β-Catenin Predicts Clinical Outcomes in Patients with Hepatocellular Carcinoma.
    Tsai MC; Huang CC; Wei YC; Liu TT; Lin MT; Yi LN; Lin PR; Wang CC; Chu TH; Hsiao CC; Hu TH; Tai MH
    Int J Mol Sci; 2020 Mar; 21(6):. PubMed ID: 32192213
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A Clinicopathological Study of Young-onset Hepatocellular Carcinoma.
    Au KY; Chan KK; Lo RC
    Anticancer Res; 2021 Jun; 41(6):2933-2944. PubMed ID: 34083284
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Stathmin overexpression cooperates with p53 mutation and osteopontin overexpression, and is associated with tumour progression, early recurrence, and poor prognosis in hepatocellular carcinoma.
    Yuan RH; Jeng YM; Chen HL; Lai PL; Pan HW; Hsieh FJ; Lin CY; Lee PH; Hsu HC
    J Pathol; 2006 Aug; 209(4):549-58. PubMed ID: 16739096
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Significance of Aurora B overexpression in hepatocellular carcinoma. Aurora B Overexpression in HCC.
    Lin ZZ; Jeng YM; Hu FC; Pan HW; Tsao HW; Lai PL; Lee PH; Cheng AL; Hsu HC
    BMC Cancer; 2010 Aug; 10():461. PubMed ID: 20799978
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [CK19 can be used to predict the early recurrence and prognosis of HBV-related hepatocellular carcinoma patients with low AFP serum concentration after R0 radical hepatectomy].
    Wang ZS; Wu LQ; Yi X; Geng C; Li YJ; Yao RY; Hu WY; Han B
    Zhonghua Zhong Liu Za Zhi; 2012 Oct; 34(10):753-8. PubMed ID: 23291069
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Opposite roles of human pancreatitis-associated protein and REG1A expression in hepatocellular carcinoma: association of pancreatitis-associated protein expression with low-stage hepatocellular carcinoma, beta-catenin mutation, and favorable prognosis.
    Yuan RH; Jeng YM; Chen HL; Hsieh FJ; Yang CY; Lee PH; Hsu HC
    Clin Cancer Res; 2005 Apr; 11(7):2568-75. PubMed ID: 15814635
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Combination with CK19 Might Increase the Prognostic Power of Hep Par 1 in Hepatocellular Carcinoma after Curative Resection.
    Jin Y; Liang ZY; Zhou WX; Zhou L
    J Invest Surg; 2018 Oct; 31(5):412-419. PubMed ID: 28758812
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Aberrant expression of the glycolytic enzymes aldolase B and type II hexokinase in hepatocellular carcinoma are predictive markers for advanced stage, early recurrence and poor prognosis.
    Peng SY; Lai PL; Pan HW; Hsiao LP; Hsu HC
    Oncol Rep; 2008 Apr; 19(4):1045-53. PubMed ID: 18357395
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The expression of cytokeratin 19 in lymph nodes was a poor prognostic factor for hepatocellular carcinoma after hepatic resection.
    Lee CW; Kuo WL; Yu MC; Chen TC; Tsai CN; Lee WC; Chen MF
    World J Surg Oncol; 2013 Jun; 11(1):136. PubMed ID: 23758804
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cytoplasmic and/or nuclear expression of β-catenin correlate with poor prognosis and unfavorable clinicopathological factors in hepatocellular carcinoma: a meta-analysis.
    Chen J; Liu J; Jin R; Shen J; Liang Y; Ma R; Lin H; Liang X; Yu H; Cai X
    PLoS One; 2014; 9(11):e111885. PubMed ID: 25401330
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Overexpression of CCAR1 in Hepatocellular Carcinoma Associates with Poor Prognosis.
    Ha SY; Kim JH; Yang JW; Kim J; Kim B; Park CK
    Cancer Res Treat; 2016 Jul; 48(3):1065-73. PubMed ID: 26511806
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The correlation between poor prognosis and increased yes-associated protein 1 expression in keratin 19 expressing hepatocellular carcinomas and cholangiocarcinomas.
    Lee K; Lee KB; Jung HY; Yi NJ; Lee KW; Suh KS; Jang JJ
    BMC Cancer; 2017 Jun; 17(1):441. PubMed ID: 28645247
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hepatocellular carcinoma expressing cholangiocyte phenotype is a novel subtype with highly aggressive behavior.
    Lu XY; Xi T; Lau WY; Dong H; Zhu Z; Shen F; Wu MC; Cong WM
    Ann Surg Oncol; 2011 Aug; 18(8):2210-7. PubMed ID: 21308485
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.